InvestorsHub Logo
Followers 20
Posts 1716
Boards Moderated 0
Alias Born 09/09/2012

Re: biopharm post# 329964

Thursday, 04/04/2019 11:47:45 AM

Thursday, April 04, 2019 11:47:45 AM

Post# of 346112
An incredible shame how mismanaged Peregrine was. They were out of money. Ronin brought in the most viable business model of getting value out of the IP through Oncologie taking on the risk and costs, while growing the CDMO business. It's the only chance of getting a return of investment and a return on investment.


Some valid points but the Ronin approach was the only viable one. Other investors to save the IP never materialized.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News